2018 Primary Changes and Updates in Recommendations

Live attenuated influenza vaccine (LAIV4- Flu mist Quadrivalent) has been updated.  Previous two seasons (2016-17 and 2017-18) ACIP recommended that LAIV4 not be used.  For 2018-19 season, vaccination providers may choose to administer any licensed, age appropriate influenza vaccine (IIV, RIV4, or LAIV4).  You can read the official recommendations from ACIP for the 2017-2018 flu season here.  The ACIP continues to recommend annual flu vaccination with inactive influenza vaccine (IIV) or recombinant influenza vaccine (RIV) for everyone 6 months and older. See this list of approved influenza vaccines for more information

Children aged 6 months through 8 years who have previously received 2 or more doses of trivalent or quadrivalent influenza vaccine before July 1, 2018 require only 1 dose for 2018-19. Children in this age group who have not previously received ≥2 doses of trivalent or quadrivalent influenza vaccine before July 1, 2018 require 2 doses for the 2018–19 season. The interval between the 2 doses should be at least 4 weeks.  For more information and an algorithm for dosing  in this age group visit 2018-19 ACIP guidelines.

Persons with a history of egg allergy who have experienced only hives after exposure to egg and non-allergic persons should be watched for 15 minutes following vaccination to decrease the risk of injury due to syncope. Persons with severe egg allergy should be vaccinated under the supervision of a medical provider who is able to recognize and manage severe allergic conditions.

Timing of Influenza Campaigns

Health-care providers should begin offering vaccination soon after the vaccine becomes available, and if possible, by October.

Flu Vaccine from ACPHD

Each year, we distribute flu vaccine to providers who agree to certain guidelines about to whom they will administer the vaccine and how and when to report usage. Visit our Flu Vaccine Distribution Program page for more information.

Terms of Use  |  Privacy